Pre Seed Round - Allermi
Investment Firm
Overview
Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
Announced Date
May 10, 2022
Funding Type
Pre Seed
Highlights
Location
United States, North America
Social
N/A
Participant Investors
1
| Investor Name |
|---|
 Lucas Venture Group |
Round Details and Background
Allermi raised $1250000 on 2022-05-10 in Pre Seed Round
Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 10, 2022 |  Pre Seed Round - Allermi | 1 | - | 1.3M |
| Mar 16, 2023 | Seed Round - Allermi | 2 | - | 3.5M |
| Apr 01, 2024 | Series A - Allermi | - | undefined |
Recent Activity
There is no recent news or activity for this profile.